Nigeria — Where It Began
Healthcare in Nigeria is not an abstraction. It is a daily negotiation between what exists and what is needed — a gap that shows up in hospital queues, in empty pharmacy shelves, in the faces of patients who have travelled hours to see a pharmacist who may or may not have the medication they require.
As a practising pharmacist in Nigeria, Beulah worked at this frontline. She dispensed antiretrovirals to HIV patients at a time when access to those medicines still meant the difference between survival and death. She saw firsthand how pharmaceutical supply chains, workforce distribution, and health system financing were not administrative concerns — they were life and death questions.
That insight — that health outcomes are determined less by clinical knowledge than by the systems and economics surrounding it — became the intellectual thread that would run through everything that followed.
China — The Education That Changed Everything
What Beulah did next is, by any measure, extraordinary. She chose to pursue advanced pharmaceutical training not in the West, not in a familiar context, but at China's leading pharmacy institution — and she did it in Mandarin Chinese.
This was not a decision made for convenience. It was a deliberate choice to understand the pharmaceutical world from an Asian perspective — to learn from the country that manufactures a significant proportion of the world's active pharmaceutical ingredients and that has built one of the most sophisticated public health infrastructure systems in history.
The experience gave her something most global health professionals never acquire: fluency across genuinely different healthcare paradigms. Not just theoretical familiarity, but working knowledge — understanding Chinese pharmaceutical policy, supply chain architecture, and public health models from the inside, in the language in which they are designed and debated.
Scotland — The Research Dimension
The third chapter took Beulah to Scotland — to the University of Aberdeen, where she completed an MSc in Global Health and Management with Distinction, and to the Rowett Institute, where she conducted NHS-linked research on social prescribing.
The NHS represents one of the world's most studied health systems — a universal system under perpetual pressure, navigating the tension between ambition and resource, between population health and individual care. Beulah's research placed her inside that system, examining the evidence for social prescribing as a mechanism for addressing the social determinants of health.
But her distinctive contribution was the comparative lens. Where other researchers examined social prescribing within its UK context, Beulah brought her experience of community health worker models in sub-Saharan Africa — finding unexpected resonances, and drawing out lessons that travel in both directions.
The Mission — Why This Work Matters Now
The world has more data on health outcomes than at any point in history. We know which interventions work. We know how to design effective health systems. We know what Universal Health Coverage requires. We know why pharmaceutical access gaps persist.
What we lack is not knowledge. What we lack are voices that can translate that knowledge across contexts — that can speak to a WHO audience and a community pharmacist in Lagos, to an NHS policy team and a health ministry in Accra, to a health economics journal and a general readership trying to understand why their healthcare system works the way it does.
That is the role Beulah is building. A bridge. Between the evidence and the policy. Between the systems that work and the systems that are still figuring it out. Between the global conversation about health equity and the local reality of what health equity actually requires.